Cargando…
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals
This is a position paper of the Radiopharmacy Committee of the EANM (European Association of Nuclear Medicine) addressing toxicology studies for application of new diagnostic and therapeutic radiopharmaceuticals (RP) that are not approved (i.e., not having a marketing authorization or a monograph in...
Autores principales: | Koziorowski, J., Behe, M., Decristoforo, C., Ballinger, J., Elsinga, P., Ferrari, V., Kolenc Peitl, P., Todde, S., Mindt, T. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843800/ https://www.ncbi.nlm.nih.gov/pubmed/29564378 http://dx.doi.org/10.1186/s41181-016-0004-6 |
Ejemplares similares
-
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals
por: Todde, S., et al.
Publicado: (2017) -
EANM guideline on the validation of analytical methods for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2020) -
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2021) -
EANM guideline on quality risk management for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2022) -
Position statement on radiopharmaceutical production for clinical trials
por: Bormans, G., et al.
Publicado: (2017)